雷珠单抗联合激光光凝治疗视网膜黄斑水肿的效果研究  

Study on the Effect of Ranibizumab Combined With Laser Photocoagulation for Macular Edema

作　　者：平俐[1] 

机构地区：[1]内蒙古包钢医院眼科,内蒙古包头014010

出　　处：《中国卫生标准管理》2017年第5期77-78,共2页China Health Standard Management

摘　　要：目的详细分析糖尿病黄斑水肿患者在玻璃体内注射雷珠单抗联合激光光凝术治疗的临床效果。方法选我院眼科收治的糖尿病黄斑水肿患者84例作为研究对象,分为单纯使用激光光凝治疗组,雷珠单抗联合激光光凝组。对比两组患者的治疗效果。结果两组患者对比可知,术后最佳矫正视力及黄斑中心视网膜凹厚度,不良反应的发生率及患者满意度,雷珠单抗联合激光光凝组治疗效果优于单纯使用激光光凝治疗组,对比差异均有统计学意义,P<0.05。结论雷珠单抗联合激光光凝治疗组比激光光凝治疗组的效果好,且其持续效果更为显著。Objective To analyzed the clinical effect of ranibizumab and laser photocoagulation in patients with diabetic macular edema. Methods A total of 84 patients with diabetic macular edema in our hospital were selected and divided into two groups： the treatment group was treated with laser photocoagulation alone, and the ranibizumab and laser photocoagulation group was treated with laser photocoagulation. The therapeutic effects of two groups were compared. Results The two groups were compared, the best corrected visual acuity and macular retinal thickness of the fovea, the adverse reaction rate and patient satisfaction, ranibizumab combined with laser photocoagulation in treatment group was better than that of simple laser photocoagulation treatment group, differences were statistically significant, P 〈 0.05. Conclusion The therapeutic effect of the combined treatment group was better than that of laser photocoagulation group, and the effect was more significant.

关 键 词：视网膜中央静脉阻塞 黄斑水肿 雷珠单抗 激光光凝 

分 类 号：R774[医药卫生—眼科]